Journal article
Cell genomics and immunosuppressive biomarker expression influence PD-L1 immunotherapy treatment responses in HNSCC-a computational study
Oral surgery, oral medicine, oral pathology and oral radiology, Vol.124(2), pp.157-164
08/2017
DOI: 10.1016/j.oooo.2017.05.474
PMCID: PMC5539917
PMID: 28756882
Abstract
Programmed death-ligand 1 (PD-L1) expression is correlated with objective response rates to PD-1 and PD-L1 immunotherapies. However, both immunotherapies have only demonstrated 12%-24.8% objective response rates in patients with head and neck squamous cell carcinoma (HNSCC), demonstrating a need for a more accurate method to identify those who will respond before their therapy. Immunohistochemistry to detect PD-L1 reactivity in tumors can be challenging, and additional methods are needed to predict and confirm PD-L1 expression. Here, we hypothesized that HNSCC tumor cell genomics influences cell signaling and downstream effects on immunosuppressive biomarkers and that these profiles can predict patient clinical responses.
We identified deleterious gene mutations in SCC4, SCC15, and SCC25 and created cell line-specific predictive computational simulation models. The expression of 24 immunosuppressive biomarkers were then predicted and used to sort cell lines into those that would respond to PD-L1 immunotherapy and those that would not.
SCC15 and SCC25 were identified as cell lines that would respond to PD-L1 immunotherapy treatment and SCC4 was identified as a cell line that would not likely respond to PD-L1 immunotherapy treatment.
This approach, when applied to HNSCC cells, has the ability to predict PD-L1 expression and predict PD-1- or PD-L1-targeted treatment responses in these patients.
Details
- Title: Subtitle
- Cell genomics and immunosuppressive biomarker expression influence PD-L1 immunotherapy treatment responses in HNSCC-a computational study
- Creators
- Amber M Bates - Iowa Institute for Oral Health Research, College of Dentistry, University of Iowa, Iowa City, IA, USAEmily A Lanzel - Department of Oral Pathology, Radiology and Medicine, College of Dentistry, University of Iowa, Iowa City, IA, USAFang Qian - Iowa Institute for Oral Health Research, College of Dentistry, University of Iowa, Iowa City, IA, USA; Division of Biostatistics and Research Design, College of Dentistry, University of Iowa, Iowa City, IA, USATaher Abbasi - Cellworks Group, Inc., San Jose, CA, USAShireen Vali - Cellworks Group, Inc., San Jose, CA, USAKim A Brogden - Iowa Institute for Oral Health Research, College of Dentistry, University of Iowa, Iowa City, IA, USA. Electronic address: Kim-brogden@uiowa.edu
- Resource Type
- Journal article
- Publication Details
- Oral surgery, oral medicine, oral pathology and oral radiology, Vol.124(2), pp.157-164
- DOI
- 10.1016/j.oooo.2017.05.474
- PMID
- 28756882
- PMCID
- PMC5539917
- NLM abbreviation
- Oral Surg Oral Med Oral Pathol Oral Radiol
- ISSN
- 2212-4403
- eISSN
- 2212-4411
- Publisher
- United States
- Grant note
- R01 DE014390 / NIDCR NIH HHS T90 DE023520 / NIDCR NIH HHS
- Language
- English
- Date published
- 08/2017
- Academic Unit
- Preventive and Community Dentistry; Oral Pathology, Radiology and Medicine; Dental Research; Periodontics
- Record Identifier
- 9984065804502771
Metrics
21 Record Views